Enter your login e-mail to the account
Search
- Současnost a perspektivy léčby dyslipidémií
doc. MUDr. Jan Bultas, CSc., MUDr. Debora Karetová
(1/2004, Main topic ) - Prehliadka zomrelých
MUDr. JUDr. Peter Kováč
(2/2004, Consilium ) - The choice of antidiabetic medications with regard to metabolic syndrome
doc. MUDr. Alena Šmahelová, PhD.
(11/2009, Review articles ) - Evolokumab pro léčbu familiární hypercholesterolémie
prof. MUDr. Vladimír Bláha, CSc.
(4/2018, Drugs & drug classes ) - Future of hypolipidemic therapy
MUDr. Fábryová Ľubomíra, PhD.
(5/2010, Topic of the year ) - ELEVATED „LIVER ENZYMES“ IN HEPATOLOGIC OFFICE/CLINICAL PRACTICE – CASE REPORTS
prof. MUDr. Jozef Holomáň, CSc.
(4-5/2008, From practice ) - HYPOLIPIDEMIKÁ V REÁLNEJ PRAXI A V PERSPEKTÍVE
prof. MUDr. Milan Kriška, DrSc.
(10/2007, clearly ) - Klinické prejavy systémového lupus erytematozus
MUDr. Ivana Révayová
(2/2005, Topic )
- Idiopatická ľahká kognitívna dysfunkcia
doc. MUDr. Egon Kurča, PhD.
(1/2004, Main topic )
- HYPOLIPIDEMIKÁ V REÁLNEJ PRAXI A V PERSPEKTÍVE
prof. MUDr. Milan Kriška, DrSc., MUDr. Ján Kriška
(1/2008, Drug classes )
- Niacin-laropiprant combination: novel approach not only to treatment of dyslipidemia Complex management of dyslipidemia provides a chance of further reduction of atherosclerotic vascular
MUDr. Michal Vrablík, Ph.D., MUDr. Eva Motyková, prof. MUDr. Richard Češka, CSc.
(1/2011, New medicinal substances )
- Pharmacological treatment of peripheral arterial disease of lower limbs from a vascular surgeon’s point of view
prof. MUDr. Vladimír Šefránek, PhD.
(3-4/2012, Review articles )